TAKHZYRO sol inj 300 mg/2ml seringue préremplie
7680681780014
CH-68178
B06AC05
02.99.0.
Reimbursement limitations:
TAKHZYRO3
En monothérapie pour la prophylaxie à long terme des crises d'angioœdème héréditaire (AOH) de type …
1 / 3
google
Details
- Product number
- 6817801
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- lanadelumabum 300 mg, dinatrii phosphas dihydricus, acidum citricum monohydricum, histidinum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 6.91 mg.
Articles (1)
TAKHZYRO 300 mg, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.91 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 9964.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2021
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 68178
- Drug name
- TAKHZYRO, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- B06AC05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/11/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAKHZYRO sol inj 300 mg/2ml seringue préremplie
- Description (DE)
- TAKHZYRO Inj Lös 300 mg/2ml Fertigspritze
- Market launch
- 05/11/2020
- Narcotic (BTM)
- No